BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11561752)

  • 1. Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.
    Kavalar R; Sarcevic B; Spagnoli GC; Separovic V; Samija M; Terracciano L; Heberer M; Juretic A
    Virchows Arch; 2001 Aug; 439(2):127-31. PubMed ID: 11561752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pS2 expression in infiltrating ductal carcinoma of the breast correlates with oestrogen receptor positivity but not with histological grade and lymph node status.
    Looi LM; Azura WW; Cheah PL; Ng MH
    Pathology; 2001 Aug; 33(3):283-6. PubMed ID: 11523925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
    Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
    Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
    Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
    Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers.
    Kanngurn S; Thongsuksai P; Chewatanakornkul S
    Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma.
    Umekita Y; Yoshida H
    Histopathology; 2003 Jun; 42(6):541-5. PubMed ID: 12786889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.
    Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J
    Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.
    Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    J Clin Pathol; 2005 Jun; 58(6):645-9. PubMed ID: 15917419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.
    Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A
    Oncology; 2003; 64(4):443-9. PubMed ID: 12759544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
    Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
    J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
    Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
    Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.